{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:34:10Z","timestamp":1751589250436},"reference-count":13,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T00:00:00Z","timestamp":1205366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>This study aimed to assess the fibrinolytic inhibitors and their association with thrombosis in Beh\u00e7et disease. Thrombin activatable fibrinolysis inhibitor (TAFI) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030\u00b7001) and plasminogen activator inhibitor\u20101 (PAI\u20101) levels (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7022) were significantly higher in 79 patients than in 84 controls. No significant differences were observed in <jats:italic>CPB2<\/jats:italic> (<jats:italic>TAFI<\/jats:italic>) Thr325Ile and <jats:italic>SERPINE1<\/jats:italic> (<jats:italic>PAI1<\/jats:italic>) 4G\/5G polymorphism distribution between patients and controls. TAFI activity levels were significantly higher in patients with thrombosis than in those without thrombosis (<jats:italic>P\u2003<\/jats:italic>=<jats:italic>\u2003<\/jats:italic>0\u00b7024). In conclusion, the increased TAFI levels in Beh\u00e7et disease could contribute to the increased risk of thrombosis observed in these patients.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07078.x","type":"journal-article","created":{"date-parts":[[2008,3,13]],"date-time":"2008-03-13T19:43:32Z","timestamp":1205437412000},"page":"716-719","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Fibrinolytic inhibitor levels and polymorphisms in Beh\u00e7et disease and their association with thrombosis"],"prefix":"10.1111","volume":"141","author":[{"given":"Jos\u00e9 M.","family":"Ricart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Vay\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria\u2010Luisa","family":"Santaolaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Todol\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remedios","family":"Castell\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Fontcuberta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amparo","family":"Estell\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,4,15]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.20.12.2511"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.09.010"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01048-8"},{"key":"e_1_2_6_5_1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1160\/TH04-08-0497","article-title":"Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform\u2010dependent artefact","volume":"94","author":"Frere C.","year":"2005","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01388.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646409"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000015445.22243.F4"},{"key":"e_1_2_6_9_1","first-page":"402","article-title":"Vascular involvement in Beh\u00e7et\u2019s disease","volume":"19","author":"Ko\u00e7 Y.","year":"1992","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06117.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05072.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1160\/TH05-10-0659","article-title":"Thrombophilic risk factors and homocysteine levels in Beh\u00e7et\u2019s disease in eastern Spain and their association with thrombotic events","volume":"95","author":"Ricart J.M.","year":"2006","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_6_13_1","first-page":"1","article-title":"PAI\u20101 promoter 4G\/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects","volume":"110","author":"Segu\u00ed R.","year":"2000","journal-title":"British Journal of Haematology"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04549.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07078.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07078.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T21:50:57Z","timestamp":1697406657000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07078.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,15]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07078.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07078.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,15]]},"assertion":[{"value":"2008-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}